Co-morbidity in patients with early rheumatoid arthritis - inflammation matters

Arthritis Research & Therapy
Lena InnalaSolveig Wållberg-Jonsson

Abstract

Patients with rheumatoid arthritis (RA) suffer from co-morbidities that contribute to a shortened lifespan. Inflammation is important for the development of cardiovascular disease, but little is known on its relationship with other co-morbidities. We investigated the role of inflammation for the development of new comorbidities in early RA. Since 1995, all patients with early RA in Northern Sweden are included in a prospective study on co-morbidities, with a total of 950 patients being included. At the time for this study, 726 had been ill for ≥5 years. Data on co-morbidities, clinical and laboratory disease activity and pharmacological therapy were collected from patient records and further validated using a questionnaire at RA onset (T0) and after 5 years (T5). Of the patients, 53.2 % of the patients had one or more co-morbidity at onset, the commonest being: hypertension (27.3 %), obstructive pulmonary disease (13.9 %), diabetes (8.0 %), hypothyroidism (6.3 %) and malignancy (5.0 %). After 5 years, 41.0 % had developed at least one new co-morbidity, the most common being: hypertension (15.1 %), malignancy (7.6 %), stroke/transient ischemic accident (5.1 %), myocardial infarction (4.3 %) and osteoporosis (3.7 %). Age at disea...Continue Reading

References

Apr 1, 1994·Arthritis and Rheumatism·F WolfeM A Cathey
Aug 26, 1999·Rheumatology·C TuressonU Bergström
Oct 16, 2002·Annals of the Rheumatic Diseases·M RudwaleitJ Braun
May 28, 2004·Scandinavian Journal of Rheumatology·C Turesson, L T H Jacobsson
Mar 8, 2005·Arthritis and Rheumatism·Hilal Maradit-KremersSherine E Gabriel
Oct 29, 2005·Arthritis and Rheumatism·Inmaculada del RincónAgustín Escalante
Dec 13, 2005·Annals of the Rheumatic Diseases·K HyrichUNKNOWN British Society for Rheumatology Biologics Register
Sep 18, 2007·Best Practice & Research. Clinical Rheumatology·Kaleb Michaud, Frederick Wolfe
Sep 18, 2007·Best Practice & Research. Clinical Rheumatology·Adam Young, Gouri Koduri
Oct 31, 2007·Arthritis and Rheumatism·Angel GonzalezSherine E Gabriel
Apr 25, 2008·Arthritis Research & Therapy·Allison L SmittenSamy Suissa
Nov 28, 2008·Arthritis and Rheumatism·J Antonio Aviña-ZubietaDiane Lacaille
Jun 13, 2009·Arthritis Research & Therapy·Sherine E Gabriel, Kaleb Michaud
Mar 13, 2010·Rheumatology·Gouri KoduriUNKNOWN ERAS (Early Rheumatoid Arthritis Study)
Jan 5, 2011·Digestive Diseases and Sciences·Ellen C Ebert, Klaus D Hagspiel
Dec 6, 2011·Best Practice & Research. Clinical Rheumatology·Nicola J Gullick, David L Scott
Jun 28, 2012·Annals of the Rheumatic Diseases·Anne M KerolaTuomo V M Nieminen
Apr 25, 2013·Annals of the Rheumatic Diseases·Camilla BengtssonSaedis Saevarsdottir
Jul 6, 2013·Scandinavian Journal of Rheumatology·T Tiippana-KinnunenM Leirisalo-Repo
Nov 20, 2013·Current Opinion in Rheumatology·M Kristen DemoruelleV Michael Holers
Jan 23, 2014·QJM : Monthly Journal of the Association of Physicians·T-C ShenY-F Li

❮ Previous
Next ❯

Citations

Mar 17, 2016·Autoimmunity Reviews·Zoltán SzekaneczYehuda Shoenfeld
Jun 28, 2016·Clinical Reviews in Allergy & Immunology·Ivica Lazúrová, Ľubomír Tomáš
May 13, 2017·International Journal of Pharmaceutics·Shannon P CallenderShawn D Wettig
Sep 13, 2017·International Reviews of Immunology·Scott Le RossignolNagaraja Haleagrahara
Mar 8, 2018·Arthritis Care & Research·Jessica WiddifieldSasha Bernatsky
Oct 24, 2019·Rheumatology·Lotta Ljung, Marie Holmqvist
May 1, 2019·Health and Quality of Life Outcomes·Dimitrios T BoumpasAna C Hernandez Daly
Oct 31, 2019·International Journal of Rheumatology·Rajaie NamasMohammed Abuzakouk
Jul 2, 2017·Arthritis Research & Therapy·Heidi KokkonenSolbritt Rantapää-Dahlqvist
Jan 12, 2019·Arthritis Research & Therapy·Zoltán SzekaneczWillem F Lems
May 8, 2020·Rheumatology International·Lisa LindnerKatinka Albrecht
Dec 18, 2020·Rheumatology·Liselotte TidbladSaedis Saevarsdottir
Apr 10, 2019·Current Rheumatology Reviews·Yulia V PolyakovaIrina A Zborovskaya
Jun 6, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Javaid AlamSyed Nasir Abbas Bukhari
Oct 2, 2021·Scientific Reports·Anita PusztaiGabriella Szűcs
Feb 29, 2020·Recent Patents on Inflammation & Allergy Drug Discovery·Fernanda C M GallottiSara M Thomazzi
Feb 17, 2021·The Journal of Rheumatology·Tina M GundersonCynthia S Crowson

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunoassay
ESR

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.